The US is the bigger Arrhythmia Monitoring Devices market: $2.5 Bn against $109 Mn in 2023, about 23 times as large.
India grows faster: 8.5% a year, against 3.5%. The gap still grows from $2.4 Bn to $3.3 Bn by 2033.
Clinical research: 79 active trials in the US, 1 in India.
| Measure |  US |  India |
|---|---|---|
| Market size, 2023 | $2.5 Bn | $109 Mn |
| Market size, 2033 projected | $3.6 Bn | $247 Mn |
| Growth a year (CAGR) | 3.5% | 8.5% |
| Money added, 2023–2033 | $1 Bn | $138 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $7.39 | $0.07 |
| Active clinical trials | 79 | 1 |
| Full report | US report | India report |
Year by year, 2023 to 2033
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Arrhythmia Monitoring Devices, US or India?
The US is the bigger Arrhythmia Monitoring Devices market: $2.5 Bn against $109 Mn in 2023, about 23 times as large.
Which grows faster in Arrhythmia Monitoring Devices, US or India?
India grows faster: 8.5% a year, against 3.5%. The gap still grows from $2.4 Bn to $3.3 Bn by 2033.
More Arrhythmia Monitoring Devices comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.